| 1 |
32676662 | No Change in Surgical and Hospitalization Trends Despite Higher Exposure to Anti-Tumor Necrosis Factor in Inflammatory Bowel Disease in the Québec Provincial Database From 1996 to 2015. | 2021 Apr 15 |
2 |
| 2 |
34259316 | Retardant effect of dihydroartemisinin on ulcerative colitis in a JAK2/STAT3-dependent manner. | 2021 Aug 31 |
1 |
| 3 |
32047894 | Risk of Postoperative Infectious Complications From Medical Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. | 2020 Nov 19 |
3 |
| 4 |
30329067 | Treatment Persistence of Infliximab Versus Adalimumab in Ulcerative Colitis: A 16-Year Single-Center Experience. | 2019 Apr 11 |
2 |
| 5 |
30420398 | Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohorts. | 2019 Jun |
4 |
| 6 |
29080069 | 5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects. | 2018 Feb |
3 |
| 7 |
30630805 | Efficacy of mesalazine in combination with bifid triple viable capsules on ulcerative colitis and the resultant effect on the inflammatory factors. | 2018 Nov |
1 |
| 8 |
26896068 | Combination of metformin and 5-aminosalicylic acid cooperates to decrease proliferation and induce apoptosis in colorectal cancer cell lines. | 2016 Feb 19 |
1 |
| 9 |
25488057 | Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials. | 2015 Mar |
1 |
| 10 |
25574095 | Frequency and associated factors of hair loss among patients with inflammatory bowel disease. | 2015 Jan 7 |
1 |
| 11 |
24056767 | Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011. | 2014 Oct |
1 |
| 12 |
24982311 | Effect of tumor necrosis factor-α inhibitors on drug-induced pancreatitis in inflammatory bowel disease. | 2014 Oct |
1 |
| 13 |
25320942 | [Mesalazine-related interstitial lung disease: an under-diagnosed effect?]. | 2014 Nov-Dec |
1 |
| 14 |
24379584 | Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis. | 2013 Dec 14 |
1 |
| 15 |
19901345 | Sulfasalazine and mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production. | 2010 Oct |
1 |
| 16 |
20926883 | State-of-the-art: Immunosuppression and biologic therapy. | 2010 |
1 |
| 17 |
17981262 | Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid. | 2008 Feb 1 |
1 |
| 18 |
16407467 | A molecular mechanism for the anti-inflammatory effect of taurine-conjugated 5-aminosalicylic acid in inflamed colon. | 2006 Apr |
2 |
| 19 |
16306769 | Increased expression of MIP-3alpha/CCL20 in peripheral blood mononuclear cells from patients with ulcerative colitis and its down-regulation by sulfasalazine and glucocorticoid treatment. | 2005 Dec |
1 |
| 20 |
10513809 | Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis. | 1999 Sep |
1 |
| 21 |
7496871 | Modulation of cytokine release from human monocytes by drugs used in the therapy of inflammatory bowel diseases. | 1995 Aug |
1 |
| 22 |
1499439 | Cytokine effects in a human colonic goblet cell line. Cellular damage and its partial prevention by 5 aminosalicylic acid. | 1992 Aug |
1 |